Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $18.59 in the prior trading day, Corbus Pharmaceuticals Holdings Inc (NASDAQ: CRBP) closed at $17.94, down -3.50%. In other words, the price has decreased by -$3.50 from its previous closing price. On the day, 0.56 million shares were traded. CRBP stock price reached its highest trading level at $18.89 during the session, while it also had its lowest trading level at $17.407.
Ratios:
Our goal is to gain a better understanding of CRBP by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 13.84 and its Current Ratio is at 13.84. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wedbush on July 30, 2024, initiated with a Outperform rating and assigned the stock a target price of $85.
On June 26, 2024, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $85.B. Riley Securities initiated its Buy rating on June 26, 2024, with a $85 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 20 ’24 when Cormorant Asset Management, LP bought 350,000 shares for $20.01 per share. The transaction valued at 7,003,761 led to the insider holds 2,375,000 shares of the business.
CATLIN AVERY W bought 888 shares of CRBP for $50,109 on Sep 04 ’24. On Jun 14 ’24, another insider, Moran Sean F., who serves as the Chief Financial Officer of the company, sold 9,355 shares for $49.87 each. As a result, the insider received 466,569 and left with 48,605 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CRBP now has a Market Capitalization of 216067568 and an Enterprise Value of 62747908.
Stock Price History:
Over the past 52 weeks, CRBP has reached a high of $61.90, while it has fallen to a 52-week low of $3.03. The 50-Day Moving Average of the stock is -32.84%, while the 200-Day Moving Average is calculated to be -54.17%.
Shares Statistics:
The stock has traded on average 648.24K shares per day over the past 3-months and 351800 shares per day over the last 10 days, according to various share statistics. A total of 12.18M shares are outstanding, with a floating share count of 11.80M. Insiders hold about 3.09% of the company’s shares, while institutions hold 105.97% stake in the company. Shares short for CRBP as of 1728950400 were 2749452 with a Short Ratio of 3.67, compared to 1726185600 on 1259138. Therefore, it implies a Short% of Shares Outstanding of 2749452 and a Short% of Float of 27.500000000000004.
